Sociology

Long-term effects of psychedelic drugs: A systematic review

Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K., Davoli, C. C., & Davis, A. K. | Neuroscience & Biobehavioral Reviews | 15 March 2020

Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects.

Lancelotta, R. L., & Davis, A. K. | Journal of Psychoactive Drugs | 09 Mar 2020

A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamine

Palamar, J. J., & Acosta, P. | Clinical and Experimental | 07 January 2020

Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers

Hutten, N. R., Mason, N. L., Dolder, P. C., & Kuypers, K. P. | Frontiers in psychiatry | 13 September 2019

Replication and extension of a model predicting response to psilocybin

Russ, S. L., Carhart-Harris, R. L., Maruyama, G., & Elliott, M. S. | Psychopharmacology | 15 June 2019

Collective self-experimentation in patient-led research: How online health communities foster innovation

Kempner, J., & Bailey, J. | Social Science & Medicine | 11 June 2019

Motives and side-effects of microdosing with psychedelics among users

Hutten, N. R., Mason, N. L., Dolder, P. C., & Kuypers, K. P. | International Journal of Neuropsychopharmacology | 31 May 2019

Embracing Neurodiversity in Psychedelic Science: A Mixed-Methods Inquiry into the MDMA Experiences of Autistic Adults

Danforth, A. L. | Journal of psychoactive drugs | 25 Mar 2019

Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers

Erritzoe, D., Smith, J., Fisher, P. M., Carhart-Harris, R., Frokjaer, V. G., & Knudsen, G. M.| Journal of Psychopharmacology | 28 February 2019

The tripping point: The potential role of psychedelic-assisted therapy in the response to the opioid crisis

Argento, E., Tupper, K. W., & Socias, M. E. | International Journal of Drug Policy | 7 February 2019

Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users

Ona, G., Kohek, M., Massaguer, T., Gomariz, A., Jiménez, D. F., Dos Santos, R. G., & Bouso, J. C. | Journal of psychoactive drugs | 7 February 2019

A Jamesian Response to Reductionism in the Neuropsychology of Religious Experience

Kime, K. G., & Snarey, J. R. | Archive for the Psychology of Religion | 13 December 2018

Classic Psychedelics: An integrative review of epidemiology, mystical experience, brain network function, and therapeutics

Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. | Pharmacology & therapeutics | 4 December 2018

Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits

Domínguez-Clavé, E., Soler, J., Pascual, J. C., Elices, M., Franquesa, A., Valle, M., ... & Riba, J. | Psychopharmacology | 7 November 2018

Dimensions of consciousness and the psychedelic state

Bayne, T., & Carter, O. | Neuroscience of consciousness | 19 September 2018

Psychedelics, Meditation, and Self-Consciousness

Millière, R., Carhart-Harris, R. L., Roseman, L., Trautwein, F. M., & Berkovich-Ohana, A. | Frontiers in psychology | 4 September 2018

Legitimate Medicine in the Age of Consumerism

Lamkin, M. | 21 August 2018

A Survey of American Psychiatrists’ Attitudes Toward Classic Hallucinogens

Barnett, B. S., Siu, W. O., & Pope Jr, H. G. | The Journal of nervous and mental disease | 1 June 2018

Are Ecstasy Induced Serotonergic Alterations Overestimated For The Majority Of Users?

Szigeti, B., Winstock, A. R., Erritzoe, D., & Maier, L. J. | Journal of Psychopharmacology | 7 May 2018

The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption

Davis, A. K., Barsuglia, J. P., Lancelotta, R., Grant, R. M., & Renn, E. | Journal of Psychopharmacology | 30 April 2018